tetano
Editor, Senior Moderator
Clin Transl Med
. 2022 Jan;12(1):e704.
doi: 10.1002/ctm2.704.
Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes
Laia Reverté[SUP] 1 2 3 [/SUP], Elena Yeregui[SUP] 1 2 [/SUP], Montserrat Olona[SUP] 1 2 3 4 [/SUP], Alicia Gutiérrez-Valencia[SUP] 5 6 [/SUP], Maria José Buzón[SUP] 7 [/SUP], Anna Martí[SUP] 1 2 [/SUP], Frederic Gómez-Bertomeu[SUP] 1 4 [/SUP], Teresa Auguet[SUP] 1 2 4 [/SUP], Luis F López-Cortés[SUP] 5 6 [/SUP], Joaquin Burgos[SUP] 7 [/SUP], Clara Benavent-Bofill[SUP] 1 [/SUP], Carme Boqué[SUP] 1 4 [/SUP], Graciano García-Pardo[SUP] 1 2 4 [/SUP], Ezequiel Ruiz-Mateos[SUP] 5 6 [/SUP], Maria Teresa Mestre[SUP] 1 [/SUP], Francesc Vidal[SUP] 1 2 3 4 [/SUP], Consuelo Viladés[SUP] 1 2 3 4 [/SUP], Joaquim Peraire[SUP] 1 2 3 4 [/SUP], Anna Rull[SUP] 1 2 3 4 [/SUP], COVIDOMICS Study Group
Affiliations
No abstract available
. 2022 Jan;12(1):e704.
doi: 10.1002/ctm2.704.
Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes
Laia Reverté[SUP] 1 2 3 [/SUP], Elena Yeregui[SUP] 1 2 [/SUP], Montserrat Olona[SUP] 1 2 3 4 [/SUP], Alicia Gutiérrez-Valencia[SUP] 5 6 [/SUP], Maria José Buzón[SUP] 7 [/SUP], Anna Martí[SUP] 1 2 [/SUP], Frederic Gómez-Bertomeu[SUP] 1 4 [/SUP], Teresa Auguet[SUP] 1 2 4 [/SUP], Luis F López-Cortés[SUP] 5 6 [/SUP], Joaquin Burgos[SUP] 7 [/SUP], Clara Benavent-Bofill[SUP] 1 [/SUP], Carme Boqué[SUP] 1 4 [/SUP], Graciano García-Pardo[SUP] 1 2 4 [/SUP], Ezequiel Ruiz-Mateos[SUP] 5 6 [/SUP], Maria Teresa Mestre[SUP] 1 [/SUP], Francesc Vidal[SUP] 1 2 3 4 [/SUP], Consuelo Viladés[SUP] 1 2 3 4 [/SUP], Joaquim Peraire[SUP] 1 2 3 4 [/SUP], Anna Rull[SUP] 1 2 3 4 [/SUP], COVIDOMICS Study Group
Affiliations
- PMID: 35075803
- DOI: 10.1002/ctm2.704
No abstract available